Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $40.2800 (-6.09%) ($40.2600 - $40.2800) on Wed. Apr. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.11% (three month average) | RSI | 39 | Latest Price | $40.2800(-6.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(65%) IWO(61%) IWC(59%) IBUY(58%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.555% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-12%) TBT(-7%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.555% (StdDev 5.11%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $43.72 | 5 Day Moving Average | $42.25(-4.66%) | 10 Day Moving Average | $41.46(-2.85%) | 20 Day Moving Average | $43.72(-7.87%) | To recent high | -55.7% | To recent low | 1.2% | Market Cap | $2.502b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |